Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000899140-26-000173·MONTANOVA CAPITAL, LLC
Schedule 13D ownership disclosure
VeraDermics, Inc.
Common Stock, par value $0.00001 · CUSIP: 922967104
Event date: 2026-02-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SUVRETTA CAPITAL MANAGEMENT, LLCReported CIK 0001569064
Shares: 4,168,991 · Class: 11.9%
- Averill Master Fund, Ltd.Reported CIK 0001939329
Shares: 3,648,538 · Class: 10.4%
- Averill Madison Master Fund, Ltd.Reported CIK 0002021243
Shares: 520,453 · Class: 1.5%
- Aaron CowenReported CIK 0001869640
Shares: 4,168,991 · Class: 11.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-26-000173
- Form type
- SCHEDULE 13D
- Filer
- MONTANOVA CAPITAL, LLC
- CIK
- CIK 1569064
- Filed
- Feb 11, 2026
- Reporting period
- Feb 05, 2026
- Description
- Schedule 13D beneficial ownership